GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,438,000 | +6.8% | 1,601,954 | +7.9% | 0.06% | +23.1% |
| Q1 2022 | $61,261,000 | +2.2% | 1,484,980 | +3.4% | 0.05% | +8.3% |
| Q4 2021 | $59,928,000 | +13.4% | 1,435,922 | -2.9% | 0.05% | +2.1% |
| Q3 2021 | $52,852,000 | -7.1% | 1,478,986 | -2.9% | 0.05% | -9.6% |
| Q2 2021 | $56,919,000 | +16.6% | 1,523,441 | +10.1% | 0.05% | +6.1% |
| Q1 2021 | $48,811,000 | -12.9% | 1,383,884 | -10.7% | 0.05% | -19.7% |
| Q4 2020 | $56,025,000 | -43.0% | 1,549,503 | -42.5% | 0.06% | -50.4% |
| Q3 2020 | $98,299,000 | -16.8% | 2,692,537 | -9.5% | 0.12% | -22.2% |
| Q2 2020 | $118,104,000 | -4.6% | 2,975,117 | -11.0% | 0.16% | -19.4% |
| Q1 2020 | $123,736,000 | -25.2% | 3,341,839 | -7.0% | 0.20% | -6.7% |
| Q4 2019 | $165,331,000 | +12.8% | 3,592,084 | +2.2% | 0.21% | +2.9% |
| Q3 2019 | $146,592,000 | +1.5% | 3,513,845 | -2.6% | 0.20% | -1.9% |
| Q2 2019 | $144,431,000 | -6.8% | 3,608,976 | -4.6% | 0.21% | -11.5% |
| Q1 2019 | $154,890,000 | +7.1% | 3,783,700 | -2.0% | 0.24% | -6.7% |
| Q4 2018 | $144,576,000 | -12.8% | 3,862,206 | -8.2% | 0.25% | -1.6% |
| Q3 2018 | $165,871,000 | -2.0% | 4,208,923 | -1.6% | 0.26% | -10.2% |
| Q2 2018 | $169,273,000 | -0.1% | 4,279,390 | -1.4% | 0.28% | -6.2% |
| Q1 2018 | $169,495,000 | +21.7% | 4,338,226 | +10.4% | 0.30% | +18.8% |
| Q4 2017 | $139,328,000 | -19.7% | 3,928,053 | -8.1% | 0.26% | -26.4% |
| Q3 2017 | $173,606,000 | +13.0% | 4,276,004 | +17.8% | 0.35% | +4.8% |
| Q2 2017 | $153,656,000 | +13.1% | 3,628,731 | +10.5% | 0.33% | +5.4% |
| Q1 2017 | $135,827,000 | +20.3% | 3,283,435 | +12.0% | 0.32% | +9.4% |
| Q4 2016 | $112,936,000 | -26.5% | 2,932,630 | -19.2% | 0.29% | -31.3% |
| Q3 2016 | $153,710,000 | +6.7% | 3,627,828 | +7.4% | 0.42% | -7.1% |
| Q2 2016 | $143,994,000 | +15.5% | 3,377,148 | +9.2% | 0.45% | +6.9% |
| Q1 2016 | $124,713,000 | +13.7% | 3,091,760 | +13.7% | 0.42% | +7.4% |
| Q4 2015 | $109,722,000 | +0.8% | 2,719,255 | -4.0% | 0.39% | -11.5% |
| Q3 2015 | $108,899,000 | -9.1% | 2,832,231 | -1.5% | 0.44% | -3.5% |
| Q2 2015 | $119,759,000 | +8.0% | 2,875,356 | +19.6% | 0.46% | -5.5% |
| Q1 2015 | $110,938,000 | +30.0% | 2,403,865 | +20.4% | 0.49% | +16.8% |
| Q4 2014 | $85,364,000 | +0.6% | 1,997,276 | +8.2% | 0.42% | -14.4% |
| Q3 2014 | $84,826,000 | +27.9% | 1,845,254 | +48.7% | 0.49% | +19.1% |
| Q2 2014 | $66,344,000 | +20.9% | 1,240,544 | +20.8% | 0.41% | +8.8% |
| Q1 2014 | $54,865,000 | +10.7% | 1,026,854 | +10.6% | 0.38% | +1.1% |
| Q4 2013 | $49,578,000 | +13.9% | 928,591 | +7.0% | 0.37% | -1.1% |
| Q3 2013 | $43,527,000 | +7.9% | 867,590 | +7.5% | 0.38% | -1.3% |
| Q2 2013 | $40,326,000 | – | 807,003 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |